Life sciences company Element Biosciences sued Illumina on Monday in separate cases in federal courts in California and Delaware, alleging that the gene-sequencing giant violated antitrust law and infringed its patents.
Sign up here.
San Diego-based Element also accused Illumina of driving up prices for gene sequencing services, suppressing innovation and limiting choice.
In a statement, Element said it filed the lawsuits “because we believe Illumina has engaged in … [1165 chars]
Source: Reuters | Published: 2025-09-22T21:17:10Z
Credit: Reuters
